View in EDS

Reply to: 'Real-world prevalence across 159 872 patients with cancer supports the clinical utility of TMB-H to define metastatic solid tumors for treatment with pembrolizumab.' by D. Fabrizio et al.

Saved in:
Bibliographic Details
Title: Reply to: 'Real-world prevalence across 159 872 patients with cancer supports the clinical utility of TMB-H to define metastatic solid tumors for treatment with pembrolizumab.' by D. Fabrizio et al.
Authors: McGrail, D.J.1 djmcgrail@mdanderson.org, Pilié, P.G.2, Rashid, N.U.3,4, Voorwerk, L.5, Slagter, M.6,7,8, Kok, M.5,9, Jonasch, E.2, Khasraw, M.10, Heimberger, A.B.11,12, Ueno, N.T.13, Ferrarotto, R.14, Chang, J.T.15,16, Lin, S.-Y.1 sylin@mdanderson.org
Source: Annals of Oncology. Sep2021, Vol. 32 Issue 9, p1194-1197. 4p.
Database: Academic Search Ultimate
FullText Text:
  Availability: 0
Header DbId: asn
DbLabel: Academic Search Ultimate
An: 152687671
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Reply to: 'Real-world prevalence across 159 872 patients with cancer supports the clinical utility of TMB-H to define metastatic solid tumors for treatment with pembrolizumab.' by D. Fabrizio et al.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22McGrail%2C+D%2EJ%2E%22">McGrail, D.J.</searchLink><relatesTo>1</relatesTo><i> djmcgrail@mdanderson.org</i><br /><searchLink fieldCode="AR" term="%22Pilié%2C+P%2EG%2E%22">Pilié, P.G.</searchLink><relatesTo>2</relatesTo><br /><searchLink fieldCode="AR" term="%22Rashid%2C+N%2EU%2E%22">Rashid, N.U.</searchLink><relatesTo>3,4</relatesTo><br /><searchLink fieldCode="AR" term="%22Voorwerk%2C+L%2E%22">Voorwerk, L.</searchLink><relatesTo>5</relatesTo><br /><searchLink fieldCode="AR" term="%22Slagter%2C+M%2E%22">Slagter, M.</searchLink><relatesTo>6,7,8</relatesTo><br /><searchLink fieldCode="AR" term="%22Kok%2C+M%2E%22">Kok, M.</searchLink><relatesTo>5,9</relatesTo><br /><searchLink fieldCode="AR" term="%22Jonasch%2C+E%2E%22">Jonasch, E.</searchLink><relatesTo>2</relatesTo><br /><searchLink fieldCode="AR" term="%22Khasraw%2C+M%2E%22">Khasraw, M.</searchLink><relatesTo>10</relatesTo><br /><searchLink fieldCode="AR" term="%22Heimberger%2C+A%2EB%2E%22">Heimberger, A.B.</searchLink><relatesTo>11,12</relatesTo><br /><searchLink fieldCode="AR" term="%22Ueno%2C+N%2ET%2E%22">Ueno, N.T.</searchLink><relatesTo>13</relatesTo><br /><searchLink fieldCode="AR" term="%22Ferrarotto%2C+R%2E%22">Ferrarotto, R.</searchLink><relatesTo>14</relatesTo><br /><searchLink fieldCode="AR" term="%22Chang%2C+J%2ET%2E%22">Chang, J.T.</searchLink><relatesTo>15,16</relatesTo><br /><searchLink fieldCode="AR" term="%22Lin%2C+S%2E-Y%2E%22">Lin, S.-Y.</searchLink><relatesTo>1</relatesTo><i> sylin@mdanderson.org</i>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Annals+of+Oncology%22">Annals of Oncology</searchLink>. Sep2021, Vol. 32 Issue 9, p1194-1197. 4p.
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=152687671
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.annonc.2021.06.017
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 4
        StartPage: 1194
    Titles:
      – TitleFull: Reply to: 'Real-world prevalence across 159 872 patients with cancer supports the clinical utility of TMB-H to define metastatic solid tumors for treatment with pembrolizumab.' by D. Fabrizio et al.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: McGrail, D.J.
      – PersonEntity:
          Name:
            NameFull: Pilié, P.G.
      – PersonEntity:
          Name:
            NameFull: Rashid, N.U.
      – PersonEntity:
          Name:
            NameFull: Voorwerk, L.
      – PersonEntity:
          Name:
            NameFull: Slagter, M.
      – PersonEntity:
          Name:
            NameFull: Kok, M.
      – PersonEntity:
          Name:
            NameFull: Jonasch, E.
      – PersonEntity:
          Name:
            NameFull: Khasraw, M.
      – PersonEntity:
          Name:
            NameFull: Heimberger, A.B.
      – PersonEntity:
          Name:
            NameFull: Ueno, N.T.
      – PersonEntity:
          Name:
            NameFull: Ferrarotto, R.
      – PersonEntity:
          Name:
            NameFull: Chang, J.T.
      – PersonEntity:
          Name:
            NameFull: Lin, S.-Y.
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 09
              Text: Sep2021
              Type: published
              Y: 2021
          Identifiers:
            – Type: issn-print
              Value: 09237534
          Numbering:
            – Type: volume
              Value: 32
            – Type: issue
              Value: 9
          Titles:
            – TitleFull: Annals of Oncology
              Type: main
ResultId 1